Sagimet Biosciences Inc.
General ticker "SGMT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $187.7M (TTM average)
Sagimet Biosciences Inc. follows the US Stock Market performance with the rate: 38.2%.
Estimated limits based on current volatility of 3.3%: low 5.11$, high 5.46$
Factors to consider:
- Total employees count: 10 as of 2023
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.89$, 9.54$]
- 2026-12-31 to 2027-12-31 estimated range: [3.13$, 8.02$]
Short-term SGMT quotes
Long-term SGMT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $32.74MM | $54.45MM | $56.89MM |
| Operating Income | $-30.74MM | $-54.45MM | $-56.89MM |
| Non-Operating Income | $2.86MM | $8.89MM | $5.85MM |
| R&D Expense | $19.78MM | $38.44MM | $39.05MM |
| Income(Loss) | $-27.88MM | $-45.57MM | $-51.04MM |
| Profit(Loss)* | $-27.88MM | $-45.57MM | $-51.04MM |
| Stockholders Equity | $91.06MM | $155.81MM | $111.38MM |
| Assets | $96.72MM | $160.26MM | $116.48MM |
| Operating Cash Flow | $-23.77MM | $-42.44MM | $-45.65MM |
| Investing Cash Flow | $12.58MM | $-61.68MM | $4.56MM |
| Financing Cash Flow | $86.17MM | $104.82MM | $0.28MM |
| Earnings Per Share** | $-1.53 | $-1.45 | $-1.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.